Utama › Kanser Paru-paru › Minnesota › Brooklyn Park
Kajian klinikal Kanser Paru-paru di Brooklyn Park, MN
10 kajian untuk Kanser Paru-paru sedang mencari peserta di lokasi dalam dan sekitar Brooklyn Park (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Mengambil pesertaFasa 3
- Mercy Hospital, Coon Rapids · 4 mi jauh
- North Memorial Medical Health Center, Robbinsdale · 4 mi jauh
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Mercy Hospital, Coon Rapids · 4 mi jauh
- Minnesota Oncology - Coon Rapids, Coon Rapids · 4 mi jauh
- North Memorial Medical Health Center, Robbinsdale · 4 mi jauh
- dan 2 lagi
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Mengambil pesertaFasa 3
- Mercy Hospital, Coon Rapids · 4 mi jauh
- North Memorial Medical Health Center, Robbinsdale · 4 mi jauh
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Mengambil pesertaFasa 3
- Mercy Hospital, Coon Rapids · 4 mi jauh
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Mengambil pesertaFasa 3
- Mercy Hospital, Coon Rapids · 4 mi jauh
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Allina Health Cancer Institute - Mercy Hospital, Coon Rapids · 4 mi jauh
- Minnesota Oncology Hematology, P.A., Coon Rapids · 4 mi jauh
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Mengambil pesertaFasa 3
- Minnesota Oncology Hematology PA, Coon Rapids · 4 mi jauh
- North Memorial Health Cancer Center, Robbinsdale · 4 mi jauh
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Mercy Hospital, Coon Rapids · 4 mi jauh
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2/3
- Mercy Hospital, Coon Rapids · 4 mi jauh
- North Memorial Medical Health Center, Robbinsdale · 4 mi jauh
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Mengambil pesertaKajian pemerhatian
- Mercy Hospital, Coon Rapids · 4 mi jauh
- North Memorial Medical Health Center, Robbinsdale · 4 mi jauh
- Fairview Lakes Medical Center, Wyoming · 24 mi jauh
- dan 1 lagi
Kajian Kanser Paru-paru di bandar lain
- Houston, TX78 kajian
- Boston, MA62 kajian
- New York City, NY60 kajian
- Los Angeles, CA45 kajian
- Washington, DC41 kajian
- Arlington, VA41 kajian
- Chicago, IL41 kajian
- Nashville, TN40 kajian
- Baltimore, MD40 kajian
- St. Louis, MO39 kajian
- Columbus, OH37 kajian
- Philadelphia, PA36 kajian
Kajian lain di Brooklyn Park
- Kanser Paru-paru Bukan Sel Kecil10 kajian
- Kanser Kolorektal7 kajian
- Kanser Prostat6 kajian
- Leukemia Mieloid Akut6 kajian
- Kanser Payudara6 kajian
- Kanser Endometrium5 kajian
- Melanoma5 kajian
- Kanser Ginjal (Karsinoma Sel Renal)4 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher4 kajian
- Kanser Ovari4 kajian
- Leukemia Limfositik Kronik4 kajian
- Kanser Kolon4 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.